<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1226159</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Classification of subtypes and identification of dysregulated genes in sepsis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tong</surname><given-names>Ran</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname><given-names>Xianfei</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1469561"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname><given-names>Fengyu</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname><given-names>Hongyi</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname><given-names>Huan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname><given-names>Heng</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname><given-names>Yuze</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname><given-names>Xiaojuan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname><given-names>Shaohua</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sun</surname><given-names>Tongwen</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/728554"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>General Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Henan Engineering Research Center for Critical Care Medicine</institution>, <addr-line>Zhengzhou, Henan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Zhengzhou Key Laboratory of Sepsis</institution>, <addr-line>Zhengzhou, Henan</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Academy of Medical Sciences, Zhengzhou University</institution>, <addr-line>Zhengzhou, Henan</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Wan-Jie Gu, Jinan University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Duomeng Yang, UCONN Health, United States; Zhongheng Zhang, Sir Run Run Shaw Hospital, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Tongwen Sun, <email xlink:href="mailto:suntongwen@163.com">suntongwen@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn002">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1226159</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Tong, Ding, Liu, Li, Liu, Song, Wang, Zhang, Liu and Sun</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Tong, Ding, Liu, Li, Liu, Song, Wang, Zhang, Liu and Sun</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Sepsis is a clinical syndrome with high mortality. Subtype identification in sepsis is meaningful for improving the diagnosis and treatment of patients. The purpose of this research was to identify subtypes of sepsis using RNA-seq datasets and further explore key genes that were deregulated during the development of sepsis.</p>
</sec>
<sec>
<title>Methods</title>
<p>The datasets GSE95233 and GSE13904 were obtained from the Gene Expression Omnibus database. Differential analysis of the gene expression matrix was performed between sepsis patients and healthy controls. Intersection analysis of differentially expressed genes was applied to identify common differentially expressed genes for enrichment analysis and gene set variation analysis. Obvious differential pathways between sepsis patients and healthy controls were identified, as were developmental stages during sepsis. Then, key dysregulated genes were revealed by short time-series analysis and the least absolute shrinkage and selection operator model. In addition, the MCPcounter package was used to assess infiltrating immunocytes. Finally, the dysregulated genes identified were verified using 69 clinical samples.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 898 common differentially expressed genes were obtained, which were chiefly related to increased metabolic responses and decreased immune responses. The two differential pathways (angiogenesis and myc targets v2) were screened on the basis of gene set variation analysis scores. Four subgroups were identified according to median expression of angiogenesis and myc target v2 genes: normal, myc target v2, mixed-quiescent, and angiogenesis. The genes CHPT1, CPEB4, DNAJC3, MAFG, NARF, SNX3, S100A9, S100A12, and METTL9 were recognized as being progressively dysregulated in sepsis. Furthermore, most types of immune cells showed low infiltration in sepsis patients and had a significant correlation with the key genes. Importantly, all nine key genes were highly expressed in sepsis patients.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>This study revealed novel insight into sepsis subtypes and identified nine dysregulated genes associated with immune status in the development of sepsis. This study provides potential molecular targets for the diagnosis and treatment of sepsis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>sepsis</kwd>
<kwd>subtypes</kwd>
<kwd>dysregulated genes</kwd>
<kwd>biomarker</kwd>
<kwd>immune cell infiltration</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="68"/>
<page-count count="13"/>
<word-count count="0"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Sepsis is a life-threatening organ dysfunction stemming from host response imbalance to infection. In 2017, 48.9 million septic events were reported worldwide, with 11 million sepsis-associated deaths recorded, accounting for 19.7% of total global deaths (<xref ref-type="bibr" rid="B41">Rudd et&#xa0;al., 2020</xref>). In the United States, the costs associated with sepsis treatment amounts to at least $24 billion annually (<xref ref-type="bibr" rid="B28">Liu et&#xa0;al., 2014</xref>). Sepsis is a major cause of health concern globally due to its high morbidity, high mortality, and huge economic burden (<xref ref-type="bibr" rid="B57">Weng et&#xa0;al., 2023</xref>). The World Health Organization has proposed that member states strive to identify, record and treat sepsis. Sepsis is a heterogeneous syndrome with complex and variable pathophysiological mechanisms, necessitating identification of different clinical biomarkers and phenotypes for precise therapy and optimization of outcomes (<xref ref-type="bibr" rid="B29">Liu et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B24">Komorowski et&#xa0;al., 2022</xref>).</p>
<p>With the development and wide application of high-throughput sequencing technology, bioinformatics analysis could be used to identify sepsis biomarkers and/or subclasses (<xref ref-type="bibr" rid="B68">Zhao et&#xa0;al., 2021</xref>). Zeng et&#xa0;al. found that MAPK14, FGR, RHOG, LAT, and PRKACB were progressively maladjusted in patients with sepsis and septic shock (<xref ref-type="bibr" rid="B62">Zeng et&#xa0;al., 2021</xref>). Li et&#xa0;al. found that sepsis-related pathways could be utilized for disease diagnosis, classification, and prognosis (<xref ref-type="bibr" rid="B26">Li et&#xa0;al., 2023</xref>). A study based on hierarchical clustering of gene expression profiles of neutrophils and partitioning around medoids was performed to distinguish sepsis subtypes, which were related to sepsis severity (<xref ref-type="bibr" rid="B33">Maslove et&#xa0;al., 2012</xref>). Zhang et&#xa0;al. identified two types of sepsis that showed different mortality and reaction to hydrocortisone therapy (<xref ref-type="bibr" rid="B66">Zhang et&#xa0;al., 2020b</xref>). Qi et&#xa0;al. explored some mitochondria-related genes to identify the molecular subtypes in sepsis (<xref ref-type="bibr" rid="B44">Shu et&#xa0;al., 2023</xref>). At present, there is no research on the classification of sepsis subtypes based on genes expression of differential pathways and validation of the key dysregulated genes in the development of sepsis based on clinical samples.</p>
<p>In addition, the immune response plays a significant role in the pathogenesis and development of sepsis. Immune cells release inflammatory mediators and cytokines aimed at eliminating potential pathogens in the early stage; immune-suppressive mechanisms appear in the late stage during sepsis, resulting in immune dysfunction (<xref ref-type="bibr" rid="B63">Zhang et&#xa0;al., 2023</xref>). Bioinformatics research has suggested that SLC2A6 was associated with sepsis-related mortality and correlated positively with infiltration levels of Th1 cells (<xref ref-type="bibr" rid="B25">Li et&#xa0;al., 2021</xref>). Research indicated SIGLEC9, TSPO, CKS1B, PTTG3P were significantly associated with infiltration of neutrophils and monocytes during sepsis (<xref ref-type="bibr" rid="B35">Ming et&#xa0;al., 2022</xref>). It is of great significance in clinical practice to explore the immune response aspect that is important in the development of sepsis, search key genes associated with immune cells, and elucidate the mechanisms and functions of the molecules and cells involved.</p>
<p>In this research, we analyzed gene expression profiles of sepsis patients in a public database to identify differentially expressed genes (DEGs) and perform enrichment analysis. Gene set variation analysis (GSVA) scores were determined to identify the highest and lowest pathways for dividing sepsis development stages. Short time-series expression miner (STEM) analysis and the least absolute shrinkage and selection operator (LASSO) model were used to identify key genes in sepsis development. We applied the MCPcounter package of R to analyze immune cell infiltration in sepsis. Pearson rank correlation was performed to assay the correlation between key genes and immune cells. Finally, we used clinical samples to validate key genes by reverse transcription quantitative polymerase chain reaction (RT-qPCR). This research not only divided the development stages of sepsis according to differential pathways but also systematically analyzed immune cell infiltration in sepsis. Our findings provide novel ideas for augmenting the diagnosis and treatment of sepsis.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Sepsis data source</title>
<p>Two sepsis-related datasets were retrieved from the Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>). The normalized gene expression matrix was retrieved. We included gene expression profiling based on whole-blood arrays from the GSE95233 dataset (including 102 sepsis patients and 22 healthy controls) and the GSE13904 dataset (including 158 sepsis children and 18 healthy children). All samples collection time point were shown in the <xref ref-type="supplementary-material" rid="ST1"><bold>Supplementary Tables 1</bold></xref>, <xref ref-type="supplementary-material" rid="SF2"><bold>2</bold></xref>. We applied the stat and dplyr packages in R to annotate and normalize the raw data in these two datasets.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Differential gene expression screening</title>
<p>Differential analysis was performed using the limma package of R to screen DEGs between the sepsis and control groups of the GSE95233 and GSE13904 datasets (<xref ref-type="bibr" rid="B40">Ritchie et&#xa0;al., 2015</xref>). DEGs were defined as |log<sub>2</sub>-fold change| &gt; 0.5 and <italic>P</italic> &lt; 0.05. Then, the filtered DEGs from the two datasets were merged to obtain intersection sets. Furthermore, DEGs with the same expression trend (upregulated or downregulated) in the two datasets between the sepsis and healthy control groups were further analyzed.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Enrichment analysis</title>
<p>Multiple pathway datasets (Hallmark, C1-C8 collections) were obtained from Molecular Signatures Database (<ext-link ext-link-type="uri" xlink:href="https://www.gsea-msigdb.org/gsea/msigdb">https://www.gsea-msigdb.org/gsea/msigdb</ext-link>). To explore related biological processes, gene set enrichment analysis (GSEA) was carried out to implement pathway enrichment analysis of upregulated and downregulated genes. <italic>P</italic> &lt; 0.05 was deemed to be statistically significant for enrichment analysis. The results of GSEA were displayed using the fgsea package in R.</p>
<p>GSVA was performed for the enrichment results in the GSVA package of R, and GSVA enrichment scores of each pathway were acquired (<xref ref-type="bibr" rid="B16">H&#xe4;nzelmann et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B61">Yu et&#xa0;al., 2021</xref>). Afterwards, we compared GSVA scores between the sepsis and control groups using the limma package in R, so as to identify the upregulated and downregulated pathways in septic patients relative to healthy controls.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Division of development stages in sepsis</title>
<p>Genes belonging to the highest and lowest pathways in the GSVA scores of the two datasets were extracted. Consensus clustering was implemented to select co-expressed genes of the highest and lowest pathways by the ConsensusClusterPlus package in R (<xref ref-type="bibr" rid="B21">Karasinska et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B38">Qiu et&#xa0;al., 2021</xref>). The parameters were set as follows: reps = 1000, pItem =0.8, pFeature =0.8. Then, median levels of co-expressed genes were calculated to divide sepsis samples of the GSE13904 dataset into four developmental stages.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Short time-series expression miner analysis</title>
<p>We performed STEM analysis of the GSE13904 dataset to cluster the common genes in four developmental stages of sepsis (<xref ref-type="bibr" rid="B12">Ernst and Bar-Joseph, 2006</xref>). The clustering module with <italic>P</italic> &lt; 0.05 was defined as a significant clustering module. The significantly clustered genes displayed a more obvious trend of upregulation or downregulation. The genes of the significant module for pathway enrichment analysis were obtained using the GlueGO plug-in of Cytoscape (<xref ref-type="bibr" rid="B43">Shannon et&#xa0;al., 2003</xref>).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Model building</title>
<p>We used the LASSO method for dimension reduction analysis of module genes and 5-fold cross validation to extract key genes in sepsis development (<xref ref-type="bibr" rid="B20">Kanwal et&#xa0;al., 2020</xref>). Subsequently, we performed logistic regression and random forest methods to evaluate the prediction performance of selected key genes. 5-fold cross validation was conducted to evaluate the prediction efficiency of the LASSO-selected genes. Meanwhile, we calculated the correlation between selected key genes using the circlize package in R.</p>
<p>In addition, we arranged and combined the selected key genes to construct possible logistic regression models. The areas under the receiver operating characteristics curve of each logistic regression model were calculated.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Microenvironment cell populations-counter analysis</title>
<p>Marker genes of immune cell types were acquired as described by <xref ref-type="bibr" rid="B2">Bindea et&#xa0;al. (2013)</xref>. To estimate immune cell infiltration of samples in the GSE13904 dataset, we used the microenvironment cell populations-counter algorithm with the MCPcounter package in R (<xref ref-type="bibr" rid="B1">Becht et&#xa0;al., 2016</xref>). This method stably quantified the abundance of different immunocytes. In addition, Pearson&#x2019;s correlation analysis was applied to calculate correlations between infiltration levels by different types of immunocytes, as well as correlations between key genes and various infiltration of immunocytes.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>RT-qPCR analysis of key genes</title>
<sec id="s2_8_1">
<label>2.8.1</label>
<title>Participants</title>
<p>To further validate the potential application of key genes for the diagnosis of sepsis in clinical practice, we selected in-hospital sepsis patients and non-sepsis patients in the intensive care unit (ICU) of the First Affiliated Hospital of Zhengzhou University from June 2022 to December 2022. Patients were excluded if they met any of the following criteria: age &lt; 18 years, ICU stay length &lt; 24&#xa0;h, pregnancy or lactation, malignancy, receiving immunosuppressive treatment, and AIDS patients. The patients were included in the sepsis group if they met the sepsis 3.0 diagnostic criteria (<xref ref-type="bibr" rid="B46">Singer et&#xa0;al., 2016</xref>). The inclusion criteria for the non-sepsis patients were hospitalization in the ICU owing to diseases other than sepsis during the same period. Ethics approval was obtained from the Research and Clinical Trial Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Number: 2021-KY-0467-003). Written informed consent was acquired from all patients or their surrogate decision-makers.</p>
</sec>
<sec id="s2_8_2">
<label>2.8.2</label>
<title>Data collection</title>
<p>Data for the recruited patients, including age, sex, clinical indices such as Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, and laboratory parameters such as white blood cell count, neutrophil percentage, procalcitonin, and C-reactive protein were recorded. Whole blood from patients within 24&#xa0;h of diagnosis of sepsis or non-sepsis was collected in a 5&#xa0;ml EDTA tube; red blood cell lysis buffer (Solarbio, Beijing, China) was added, and the sample was fully mixed, followed by centrifugation to isolate nucleated cells for subsequent analysis.</p>
</sec>
<sec id="s2_8_3">
<label>2.8.3</label>
<title>RNA extraction and RT-qPCR</title>
<p>Total RNA of whole blood from enrolled patients was extracted with RNAiso Plus reagent (TaKaRa, Tokyo, Japan) according to the manufacturer&#x2019;s instructions. A reverse transcription kit (US Everbright, Suzhou, China) was used to generate cDNA as a qPCR template. Quantitative PCR was performed with a Universal SYBR Green qPCR SuperMix kit (US Everbright, Suzhou, China) following the manufacturer&#x2019;s instructions. RT-qPCR analysis was performed for expression analysis with Applied Biosystems QuantStudio&#x2122; 3 (Thermo Fisher Scientific, USA). Relative expression of genes was analyzed by the 2<sup>-&#x394;&#x394;Ct</sup> method normalized to GAPDH. The primers used were as follows: GAPDH forward: 5&#x2019;- GTCAAGGCTGAGAACGGGAA-3&#x2019;, reverse: 5&#x2019;- AAATGAGCCCCAGCCTTCTC-3&#x2019;; CHPT1 forward: 5&#x2019;-AGCTCTTTGACCATGGCTGT-3&#x2019;, reverse: 5&#x2019;-TAAGTTCCTAAGCGAGCGGC-3&#x2019;; CPEB4 forward: 5&#x2019;- TGAGATCACAGCTAGTTTTCGT-3&#x2019;, reverse: 5&#x2019;- TCAATGCATGCATCAATGAGAG-3&#x2019;; DNAJC3 forward: 5&#x2019;- TTGGGATGCAGAACTACGGG-3&#x2019;, reverse: 5&#x2019;- CCCGAACTTCACTGAGGGAC-3&#x2019;; MAFG forward: 5&#x2019;- TGTAGCCCTTGTCTGCACTG-3&#x2019;, reverse: 5&#x2019;- CTGTTTTCCCGTGTTCGTTT-3&#x2019;; NARF forward: 5&#x2019;- CCGTCGACACTCTGTTTGGA-3&#x2019;, reverse: 5&#x2019;- TTGGCCGCATGTCTGAAGAT-3&#x2019;; METTL9 forward: 5&#x2019;- TTGGAGCCAACTAGAGGCAG-3&#x2019;, reverse: 5&#x2019;- CACTTGCCACCTACGTTTTCC-3&#x2019;; S100A12 forward: 5&#x2019;- CGGAAGGGGCATTTTGACACC-3&#x2019;, reverse: 5&#x2019;- TCAGCGCAATGGCTACCAGG-3&#x2019;; S100A9 forward: 5&#x2019;- TCAAAGAGCTGGTGCGAAAA-3&#x2019;, reverse: 5&#x2019;- AACTCCTCGAAGCTCAGCTG-3&#x2019;; SNX3 forward: 5&#x2019;- GCTCCCTGGGAAAGCGT-3&#x2019;, reverse: 5&#x2019;- GGATGACCAGCGACCTTGTTTA-3&#x2019;.</p>
</sec>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Statistical analysis</title>
<p>We used GraphPad Prism version 5.0 (La Jolla, CA, USA) and SPSS version 17.0 (Chicago, IL, USA) for statistical analysis. The median and 25%-75% interquartile ranges were used to assess quantitative variables; categorical variables were described as percentages. Continuous data with a normal distribution were analyzed using Student&#x2019;s t test, and those with a nonnormal distribution were analyzed with the Mann-Whitney test. Classification data were compared by the chi-square test. We set a two-tailed <italic>P</italic> value &lt; 0.05 as statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Differential expressed genes in sepsis</title>
<p>
<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref> shows the flow chart of our research. We analyzed DEGs between sepsis and control groups to identify genes associated with sepsis. A total of 3581 DEGs in the GSE95233 dataset (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>) and 1284 DEGs in the GSE13904 dataset (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>) were obtained. By comparing DEGs between the two datasets, we observed that 898 genes were common to both (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2C</bold></xref>). Specifically, we found that 774 DEGs were upregulated (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2D</bold></xref>) and 123 DEGs downregulated (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2E</bold></xref>) in the two datasets. These genes at the intersection could be closely related to both adult sepsis and pediatric sepsis.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The flow chart of this research. Sequencing data from healthy controls and sepsis samples in the GSE95233 and GSE13904 datasets were analyzed through bioinformatics in order to identify early potential biomarkers of sepsis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1226159-g001.tif"/>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Identification of common DEGs in sepsis. <bold>(A)</bold> The volcano plot of DEGs between the healthy controls and sepsis samples in the GSE95233 dataset. <bold>(B)</bold> The volcano plot of DEGs between the healthy controls and sepsis samples in the GSE13904 dataset. <bold>(C)</bold> Venn diagram of DEGs in the GSE95233 and GSE13904 datasets. <bold>(D)</bold> Venn diagram of up-regulated DEGs in the GSE95233 and GSE13904 datasets. <bold>(E)</bold> Venn diagram of down-regulated DEGs in the GSE95233 and GSE13904 datasets.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1226159-g002.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Functional enrichment of selected genes</title>
<p>Based on common DEGs, enrichment analysis results suggested that secretory granule membrane and hallmark hypoxia were upregulated in the sepsis patients compared with the healthy controls but that CD4 T-cell vs. B-cell upregulation, T-cell activation, and Deurig T-cell prolymphocytic leukemia dn were downregulated (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3A</bold></xref>). These GSEA results revealed the genes upregulated in sepsis to be mainly enriched in metabolism-related pathways; downregulated genes were principally enriched in immune-associated pathways. In addition, we used the hallmark gene set to obtain signaling pathways in which the DEGs between the sepsis and control groups in the GSE95233 and GSE13904 datasets were involved. In the two datasets, angiogenesis was the most obviously highly enriched pathway and myc targets v2 the most obviously less enriched pathway (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3B, C</bold></xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The pathway enrichment analysis of DEGs. <bold>(A)</bold> Significant up-regulated and down-regulated signaling pathways of DEGs between sepsis samples and healthy controls in the C1-C8 and Hallmark collections. The left was down-regulated signaling pathways and the right was up-regulated signaling pathways. <bold>(B)</bold> In the Hallmark collection, significant up-regulated and down-regulated signaling pathways of DEGs between sepsis samples and control samples in GSE13904, as quantified by GSVA. <bold>(C)</bold> In the Hallmark collection, significant up-regulated and down-regulated signaling pathways of DEGs between sepsis samples and healthy controls in GSE95233, as quantified by GSVA. FC, fold change; GSVA, gene set variation analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1226159-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Identification of four distinct subgroups in sepsis</title>
<p>To aid in selecting co-expressed genes of the angiogenesis and myc targets v2 pathways and relevant to sepsis biology, we used consensus clustering to obtain robustly angiogenesis (n = 11) and myc targets v2 (n = 26) pathway genes for sepsis subtyping (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4A</bold></xref>). Besides, we acquired types corresponding to the two pathways (angiogenesis=C2, myc targets v2=C3). On the basis of the median expression levels of co-expressed genes, we assigned the sepsis samples of the GSE13904 dataset to four stages: myc targets v2 (angiogenesis &#x2264; 0, myc targets v2 &gt; 0), mixed (angiogenesis &gt; 0, myc targets v2 &gt; 0), quiescent (angiogenesis &#x2264; 0, myc targets v2 &#x2264; 0), angiogenesis (angiogenesis &gt; 0, myc targets v2 &#x2264; 0) (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4B</bold></xref>). The expression levels of angiogenesis and myc targets v2 genes among the four subgroups were visualized in <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4C</bold></xref>. According to the results, we defined the development stages of sepsis in the following order: normal, myc targets v2, mixed-quiescent, angiogenesis.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Development stages of sepsis based on expression of angiogenesis and myc targets v2 genes. <bold>(A)</bold> Heatmap showing consensus clustering analysis for angiogenesis and myc targets v2 genes in sepsis samples of GSE13904. <bold>(B)</bold> Scatter plot depicting median expression levels of co-expressed angiogenesis (x-axis) and myc targets v2 (y-axis) genes in sepsis samples of GSE13904. Sepsis subgroups were divided according to the relative expression levels of angiogenesis and myc targets v2 genes. <bold>(C)</bold> Heatmap showing the expression levels of angiogenesis and myc targets v2 co-expressed genes across each subgroup.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1226159-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Key genes associated with sepsis development</title>
<p>STEM analysis was applied to select genes with persistent imbalance in module genes. In order to screen progressive dysregulation genes during the development of sepsis, we utilized STEM analysis to identify common genes. These common genes fell into four significant clusters (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5A</bold></xref>). The U42 cluster showed an obvious upregulation trend in the following order: normal &lt; myc targets v2 &lt; mixed-quiescent &lt; angiogenesis (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5B</bold></xref>). Next, we preformed pathway enrichment analysis of genes in the U42 cluster. The results showed that these genes were mainly enriched in positive regulation of inflammatory response, myeloid leukocyte activation, secretory granule lumen (<xref ref-type="supplementary-material" rid="SF1"><bold>Supplementary Figure 1</bold></xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Identification of key genes associated with sepsis development. <bold>(A)</bold> Heatmap of continuously imbalanced genes identified by STEM in sequence: normal &lt; myc targets v2 &lt; mixed-quiescent &lt; angiogenesis. Gene sets were aligned based on cluster distribution to produce simplified expression profiles. <bold>(B)</bold> The box diagrams of STEM genes in four clusters. The line diagrams and box diagrams were applied to show the fold change (log2FC) and absolutely expressed levels, respectively. Highlight representative genes with red lines. **<italic>P</italic> &lt; 0.01. <bold>(C)</bold> The gene feature selection of optimum parameter (&#x3bb;) in the LASSO model. <bold>(D)</bold> The correlation circus of key genes expression. Red indicated positive correlation and green indicated negative correlation. The depth of color represented the intensity of correlation. <bold>(E)</bold> The receiver operating characteristic curves of nine key genes by the logistic regression and random forest.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1226159-g005.tif"/>
</fig>
<p>To select the most discriminating genes dysregulated in sepsis development, we used LASSO analysis to obtain nine key genes (CHPT1, CPEB4, DNAJC3, MAFG, NARF, SNX3, S100A9, S100A12, METTL9) from the U42 cluster (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5C</bold></xref>). These key genes correlated positively with each other (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5D</bold></xref>). The nine key genes were upregulated in sepsis compared with healthy controls (<xref ref-type="supplementary-material" rid="SF2"><bold>Supplementary Figures 2A, B</bold></xref>). The area under the receiver operating characteristics curves of nine genes in the logistic regression and random forest models in the internal validation were 0.957 and 0.987, respectively (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5E</bold></xref>), which indicated that these nine genes could well predict sepsis development.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Immune cells infiltration in sepsis</title>
<p>We identified infiltration of ten immune cell types in GSE13904 by microenvironment cell populations-counter analysis (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6A</bold></xref>). The results showed that the relative abundances of neutrophils and endothelial cells in sepsis patients were significantly higher than those in healthy patients; the relative abundances of B lineage cells, T cells, cytotoxic lymphocytes, and NK cells were lower. Correlation results between immune cells suggested remarkable positive correlations for fibroblasts and CD8 T cells, cytotoxic lymphocytes and T cells (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6B</bold></xref>). In addition, we found that these key genes correlated negatively with most types of immune cells, except for endothelial cells and neutrophils (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6C</bold></xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p><bold>(A)</bold> Heatmap showing immune cells infiltration between sepsis samples and healthy controls of GSE13904. ****<italic>P</italic> &lt; 0.0001. <bold>(B)</bold> Correlation between the infiltration levels of immune cells by Pearson&#x2019;s correlation analysis. Red represented positive correlations and green represented negative correlations. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001. <bold>(C)</bold> Correlation between key genes and various infiltration of immune cells by Pearson&#x2019;s correlation analysis. Red represented positive correlations and blue represented negative correlations. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1226159-g006.tif"/>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Validation of key genes expression</title>
<p>A total of 44 sepsis patients and 25 age- and sex-matched non-sepsis patients were enrolled in our research. The baseline demographic characteristics and clinical data between the two groups are summarized in <xref ref-type="supplementary-material" rid="ST3"><bold>Supplementary Table 3</bold></xref>. The sepsis patients had significantly higher SOFA and APACHE II scores than the non-sepsis patients on the day of admission to the ICU. The median white blood cell count, neutrophil percentage, procalcitonin level, and C-reactive protein level in the sepsis group were higher than those in the non-sepsis group. In addition, expression of the nine key genes in whole blood between sepsis patients and non-sepsis patients was compared by RT-qPCR, and CHPT1, CPEB4, DNAJC3, MAFG, NARF, SNX3, S100A9, S100A12, and METTL9 levels in the sepsis group were significantly elevated compared with those in the non-sepsis group (<xref ref-type="fig" rid="f7"><bold>Figures&#xa0;7A&#x2013;I</bold></xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Identification of nine key genes expression in the whole blood between the sepsis and non-sepsis patients. <bold>(A&#x2013;I)</bold> Expression of CHPT1, CPEB4, DNAJC3, MAFG, NARF, SNX3, S100A9, S100A12, METTL9 between sepsis group and non-sepsis group, respectively. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1226159-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Sepsis remains a major public health problem (<xref ref-type="bibr" rid="B49">Tang et&#xa0;al., 2023</xref>). In this study, we employed GSVA to identify two differential pathways (angiogenesis and myc targets v2) between sepsis patients and healthy controls. Based on the co-expressed genes of the two pathways, we divided sepsis into four stages: normal, myc targets v2, mixed-quiescent, and angiogenesis. We further used STEM and LASSO analyses to screen nine key genes, CHPT1, CPEB4, DNAJC3, MAFG, NARF, SNX3, S100A9, S100A12, and METTL9, which were progressively dysregulated during the development of sepsis and had important diagnostic functions. More importantly, clinical samples from the ICU verified higher expression of the nine genes in sepsis patients than in non-sepsis patients, which supported the bioinformatics results.</p>
<p>CHPT1 is a key enzyme that participates in the synthesis of glycerophospholipids, catalyzing phosphatidylcholine synthesis and regulating choline metabolism (<xref ref-type="bibr" rid="B55">Wang et&#xa0;al., 2021</xref>). Metabolomics analysis demonstrated that serum concentrations of glycerophospholipids and the glycerophospholipid were significantly altered in sepsis (<xref ref-type="bibr" rid="B54">Wang et&#xa0;al., 2021</xref>). Our previous research also found that compared with the sham operation group, the plasma metabolites of septic rats involved in the metabolism of glycerol phospholipids and amino acids were significantly changed (<xref ref-type="bibr" rid="B4">Cui et&#xa0;al., 2020</xref>). CPEB4, a sequence specific RNA-binding protein, exits in the 3&#x2019; untranslated region of some mRNAs (<xref ref-type="bibr" rid="B19">Ivshina et&#xa0;al., 2014</xref>). Research showed CPEB4 could stabilize anti-inflammatory transcripts containing AU-rich elements and cytoplasmic polyadenylation elements in the 3&#x2019; untranslated region, which was necessary to solve the inflammatory response triggered by lipopolysaccharide (<xref ref-type="bibr" rid="B48">Su&#xf1;er et&#xa0;al., 2022</xref>). Sibilio et&#xa0;al. found that CPEB4 mediated repair and remodeling of acute inflammatory tissue injury (<xref ref-type="bibr" rid="B45">Sibilio et&#xa0;al., 2022</xref>). Inflammation and cell stress can result in the accumulation of misfolded or unfolded proteins, known as endoplasmic reticulum (ER) stress (<xref ref-type="bibr" rid="B22">Kim et&#xa0;al., 2013</xref>). Similarly, persistent ER stress can also trigger and aggravate inflammation through multiple mechanisms (<xref ref-type="bibr" rid="B65">Zhang and Kaufman, 2008</xref>). Research has shown that stress-induced loss of dynamic balance in ER function was closely related to the progression of sepsis (<xref ref-type="bibr" rid="B14">Gong et&#xa0;al., 2022</xref>), and DNAJC3 could defend cells against ER stress in response to unfolded proteins (<xref ref-type="bibr" rid="B36">Pauwels et&#xa0;al., 2022</xref>). MAFG, a small Maf protein, acts as a heterodimer chaperone with Nrf2 (<xref ref-type="bibr" rid="B27">Li and Zhan, 2022</xref>). Sepsis leads to redox imbalance, which is characterized by excessive production of reactive oxygen species. MAFG and Nrf2 were highly involved in the regulation of numerous antioxidant genes at the transcriptional level, and the Nrf2 signaling pathway could respond to excessive reactive oxygen species (<xref ref-type="bibr" rid="B3">Caggiano et&#xa0;al., 2017</xref>). NARF is a protein-coding gene that is related to mitochondria and iron-sulfur cluster binding (<xref ref-type="bibr" rid="B9">Ding et&#xa0;al., 2020</xref>). Iron-sulfur cluster, a redox regulator, is known for its role in mediating electron transfer in the mitochondrial respiratory chain (<xref ref-type="bibr" rid="B39">Read et&#xa0;al., 2021</xref>). Research showed that the iron-sulfur cluster could regulate oxidative stress through superoxide reactive protein, which might affect the progression of sepsis (<xref ref-type="bibr" rid="B23">Kobayashi et&#xa0;al., 2014</xref>). SNX3 belongs to the endosomal protein sorting nexin family, which participates in vesicular transport events, including autophagy and endocytosis (<xref ref-type="bibr" rid="B32">Maruzs et&#xa0;al., 2015</xref>). Promoting autophagy could alleviate sepsis-related organ injury, which might be a new treatment for sepsis (<xref ref-type="bibr" rid="B47">Sun et&#xa0;al., 2021</xref>). S100A9, a proinflammatory alarmin, was upregulated in a variety of infectious diseases (<xref ref-type="bibr" rid="B17">Holzinger et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B30">Marinkovi&#x107; et&#xa0;al., 2020</xref>). A study found that targeting S100A9 could reduce neutrophil recruitment and lung accumulation in sepsis, thereby improving sepsis-related lung injury (<xref ref-type="bibr" rid="B8">Ding et&#xa0;al., 2021</xref>). S100A9 usually binds with S100A8 to form heterodimer, which plays an important role in the inflammation (<xref ref-type="bibr" rid="B53">Wang et&#xa0;al., 2018</xref>). S100A8/S100A9 heterodimer was reported to help stratify and predict mortality in the septic shock patients (<xref ref-type="bibr" rid="B11">Dubois et&#xa0;al., 2020</xref>). Similarly, Davydova et&#xa0;al. suggested that septic shock patients with high levels of S100A12 and S100A8/A100A9 at admission might have a higher risk of death (<xref ref-type="bibr" rid="B10">Dubois et&#xa0;al., 2019</xref>). S100A12, similar to S100A9, belongs to the S100 gene family, which plays essential immune response role in inflammation-related diseases (<xref ref-type="bibr" rid="B42">Shah et&#xa0;al., 2017</xref>). The research indicated that expression of S100A12 and S100A9 in the peripheral blood of sepsis patients was upregulated compared with that of healthy controls (<xref ref-type="bibr" rid="B51">Uhel et&#xa0;al., 2017</xref>), which was consistent with our results. Another study reported that S100A12 promoted inflammation in sepsis-induced acute respiratory distress syndrome by activating the NLRP3 inflammasome signaling pathway (<xref ref-type="bibr" rid="B64">Zhang et&#xa0;al., 2020a</xref>). METTL9 is widely specific methyltransferase (<xref ref-type="bibr" rid="B6">Davydova et&#xa0;al., 2021</xref>). Daitoku et&#xa0;al. identified that METTL9 catalyzed formation of N&#x3c0;-methylhistidine in the S100A9, weakening its affinity for zinc (<xref ref-type="bibr" rid="B5">Daitoku et&#xa0;al., 2021</xref>). Given that S100A9 might play an antibacterial role by chelating the zinc necessary for growth of pathogenic bacteria, METTL9 mediated S100A9 methylation may participate in the innate immune response to infection.</p>
<p>Enrichment analysis revealed significant upregulation of metabolic-related pathways and downregulation of immune-related pathways in sepsis. It was reported that sepsis may lead to increased aerobic and anaerobic metabolism, abnormal fatty acid metabolism, and impaired oxygen supply (<xref ref-type="bibr" rid="B37">Ping et&#xa0;al., 2021</xref>). PKM2-dependent aerobic glycolysis promoted macrophages stimulated by lipopolysaccharide to release HMGB1 and IL-1&#x3b2; (<xref ref-type="bibr" rid="B59">Xie et&#xa0;al., 2016</xref>). Numerous studies have indicated that immunosuppression was a factor for increased susceptibility to mortality and secondary infection in sepsis, and most sepsis-mortality occurred in hypo-inflammation (<xref ref-type="bibr" rid="B13">Gandhirajan et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B50">Torres et&#xa0;al., 2022</xref>). Severe depletion of dendritic cells might be used to predict sepsis outcome in the early stage (<xref ref-type="bibr" rid="B56">Weber et&#xa0;al., 2015</xref>). Besides, sepsis-induced lymphopenia was more prominent in sepsis non-survivors than in survivors (<xref ref-type="bibr" rid="B60">Yao et&#xa0;al., 2022</xref>).</p>
<p>Sepsis could damage the innate and adaptive immune responses, which made it impossible to control various types of infections (<xref ref-type="bibr" rid="B34">McBride et&#xa0;al., 2020</xref>). Analysis of immune cell infiltration in sepsis patients indicated that most types of immunocyte infiltration decreased, except infiltration by neutrophils and endothelial cells. Due to delayed neutrophil apoptosis, neutrophils level rapidly increased in sepsis (<xref ref-type="bibr" rid="B67">Zhang et&#xa0;al., 2023</xref>). The delayed neutrophil apoptosis and formation of neutrophil extracellular traps occurred together with long-term endothelial damage and organ dysfunction (<xref ref-type="bibr" rid="B7">Denning et&#xa0;al., 2019</xref>). A significant decrease in lymphocytes (especially CD4 T lymphocytes) was well characterized in sepsis (<xref ref-type="bibr" rid="B31">Martin et&#xa0;al., 2020</xref>). In addition, circulating counts of mucosal-associated invariant T cells, natural killer T cells, and gamma delta T cells decreased significantly, the extent of which was related to increased infection risk (<xref ref-type="bibr" rid="B15">Grimaldi et&#xa0;al., 2014</xref>). A substantial decline in B-cell counts in sepsis patients was reported, secondary to T lymphocyte deficits and increased apoptosis (<xref ref-type="bibr" rid="B52">Venet et&#xa0;al., 2010</xref>). Loss of NK cells directly impacted the immune reaction of sepsis patients (<xref ref-type="bibr" rid="B18">Inoue et&#xa0;al., 2010</xref>). Furthermore, the decrease of IFN-&#x3b3; level owing to accelerated apoptosis of NK cells might increase the possibility of secondary infection in sepsis patients (<xref ref-type="bibr" rid="B58">Wesselkamper et&#xa0;al., 2008</xref>). Our research also found that most key genes positively correlated with neutrophils and endothelial cells, and negatively correlated with T cells, CD 8 cells, and NK cells. These findings further supported the potential role of biomarkers and provided new insights for immunotherapeutic targets.</p>
<p>Our research has certain limitations. Firstly, the two databases contain not only adults with sepsis and healthy controls but also children, which may affect biased interpretation of the results. Secondly, we need apply larger clinical samples (adults and children) to verify the expression levels of nine key molecules identified. Further research should explore whether these key genes are associated with the prognosis of sepsis patients.</p>
</sec>
<sec id="s5" sec-type="conclusion">
<label>5</label>
<title>Conclusion</title>
<p>In summary, our research revealed that sepsis could be divided into four developmental stages (normal, myc targets v2, mixed-quiescent, angiogenesis). In addition, we screened nine key genes that might be helpful in diagnosing and monitoring the development of sepsis. These key genes showed an inextricable link with the immunological microenvironment in sepsis. This research provides novel insight into latent molecular targets for combating sepsis and promotes a full understanding of the potential immune mechanisms involved in sepsis.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="SF1"><bold>Supplementary Material</bold></xref>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by The Research and Clinical Trial Ethics Committee of the First Affiliated Hospital of Zhengzhou University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>All the authors contributed substantially to the work presented in this article. TS, RT and XD conceived the study. FL, HYL, and HL contributed to data acquisition. HS, YW, XZ and SL contributed to data analysis. TS, RT, and XD contributed to the study protocol and wrote the article. The corresponding author had full access to all of the data and the final responsibility for the decision to submit this article for publication. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by the Fund of National Natural Science Foundation of China (Grant No. U2004110, 82172129, 82202370); The central government guides local science and technology development funds (Grant No. Z20221343037); The 2021 youth talent promotion project in Henan Province (Grant No.2021HYTP053); Medical Science and Technology Tackling Plan Provincial and Ministerial Major Projects of Henan Province (Grant No. SBGJ202101015), and 2021 joint construction project of Henan Medical Science and technology breakthrough plan (Grant No. LHGJ20210299); The Excellent Youth Science Foundation of Henan Province (Grant No. 232300421048).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank Xueyan Qi, Yi Zhou, Yali Sun, Yangyang Yuan, Yue Yuan, Yuhao Guo, and all medical staff of General ICU for their help with this study.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1226159/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1226159/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.tif" id="SF1" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Pathway enrichment analysis network diagram of genes in U42 cluster. Different colors represented different pathways and a circle corresponded to a gene.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_2.tif" id="SF2" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;2</label>
<caption>
<p><bold>(A)</bold> Differential expressed genes between healthy controls and sepsis samples in the GSE13904 dataset. <bold>(B)</bold> Differential expressed genes between healthy controls and sepsis samples in the GSE95233 dataset.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_1.docx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_2.docx" id="ST2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_3.docx" id="ST3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>ICU, intensive care unit; DEGs, differential expressed genes; GSVA, gene set variation analysis; STEM, short time-series expression miner; LASSO, least absolute shrinkage and selection operator; GEO, gene expression omnibus; GSEA, gene set enrichment analysis; RT-qPCR, reverse transcription quantitative polymerase chain reaction; SOFA, sequential organ failure assessment; APACHE II, acute physiology and chronic health evaluation II.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becht</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Giraldo</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Lacroix</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Buttard</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Elarouci</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Petitprez</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression</article-title>. <source>Genome Biol.</source> <volume>17</volume> (<issue>1</issue>), <fpage>218</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13059-016-1070-5</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bindea</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Mlecnik</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Tosolini</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kirilovsky</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Waldner</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Obenauf</surname> <given-names>A. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</article-title>. <source>Immunity</source> <volume>39</volume> (<issue>4</issue>), <fpage>782</fpage>&#x2013;<lpage>795</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.003</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caggiano</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Cattaneo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Moltedo</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Esposito</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Perrino</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Trimarco</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>miR-128 is implicated in stress responses by targeting MAFG in skeletal muscle cells</article-title>. <source>Oxid. Med. Cell. Longevity</source> <volume>2017</volume>, <fpage>9308310</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2017/9308310</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Metabolomic analysis of the effects of adipose-Derived mesenchymal stem cell treatment on rats with sepsis-Induced acute lung injury</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <elocation-id>902</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2020.00902</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daitoku</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Someya</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kako</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hayashi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Tajima</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Haruki</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>siRNA screening identifies METTL9 as a histidine N&#x3c0;-methyltransferase that targets the proinflammatory protein S100A9</article-title>. <source>J. Biol. Chem.</source> <volume>297</volume> (<issue>5</issue>), <fpage>101230</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbc.2021.101230</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davydova</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Shimazu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Schuhmacher</surname> <given-names>M. K.</given-names>
</name>
<name>
<surname>Jakobsson</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Willemen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mamMalian proteomes</article-title>. <source>Nat. Commun.</source> <volume>12</volume> (<issue>1</issue>), <fpage>891</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-20670-7</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denning</surname> <given-names>N. L.</given-names>
</name>
<name>
<surname>Aziz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gurien</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>DAMPs and NETs in sepsis</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <elocation-id>2536</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.02536</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Du</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Averitt</surname> <given-names>V. R.</given-names>
</name>
<name>
<surname>Jakobsson</surname> <given-names>G.</given-names>
</name>
<name>
<surname>R&#xf6;nnow</surname> <given-names>C. F.</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Targeting S100A9 reduces neutrophil recruitment, inflammation and lung damage in abdominal sepsis</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>23</issue>). doi: <pub-id pub-id-type="doi">10.3390/ijms222312923</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Valdivia</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>S. K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Nuclear prelamin a recognition factor and iron dysregulation in multiple sclerosis</article-title>. <source>Metab. Brain Dis.</source> <volume>35</volume> (<issue>2</issue>), <fpage>275</fpage>&#x2013;<lpage>282</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11011-019-00515-z</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Marc&#xe9;</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Faivre</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Lukaszewicz</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Junot</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Fenaille</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>High plasma level of S100A8/S100A9 and S100A12 at admission indicates a higher risk of death in septic shock patients</article-title>. <source>Sci. Rep.</source> <volume>9</volume> (<issue>1</issue>), <fpage>15660</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-52184-8</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Payen</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Junot</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Fenaille</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Morel</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Top-down and bottom-up proteomics of circulating S100A8/S100A9 in plasma of septic shock patients</article-title>. <source>J. Proteome Res.</source> <volume>19</volume> (<issue>2</issue>), <fpage>914</fpage>&#x2013;<lpage>925</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jproteome.9b00690</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ernst</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bar-Joseph</surname> <given-names>Z.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>STEM: a tool for the analysis of short time series gene expression data</article-title>. <source>BMC Bioinf.</source> <volume>7</volume>, <fpage>191</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2105-7-191</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gandhirajan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Roychowdhury</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vachharajani</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Sirtuins and sepsis: cross talk between redox and epigenetic pathways</article-title>. <source>Antioxidants (Basel Switzerland)</source> <volume>11</volume> (<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.3390/antiox11010003</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Identification of immune-related endoplasmic reticulum stress genes in sepsis using bioinformatics and machine learning</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <elocation-id>995974</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.995974</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimaldi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Le Bourhis</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Sauneuf</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dechartres</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rousseau</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ouaaz</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections</article-title>. <source>Intensive Care Med.</source> <volume>40</volume> (<issue>2</issue>), <fpage>192</fpage>&#x2013;<lpage>201</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00134-013-3163-x</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xe4;nzelmann</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Castelo</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Guinney</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>GSVA: gene set variation analysis for microarray and RNA-seq data</article-title>. <source>BMC Bioinf.</source> <volume>14</volume>, <fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2105-14-7</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holzinger</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Tenbrock</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Alarmins of the S100-family in juvenile autoimmune and auto-inflammatory diseases</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <elocation-id>182</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.00182</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Unsinger</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Muenzer</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis</article-title>. <source>J. Immunol. (Baltimore Md 1950)</source> <volume>184</volume> (<issue>3</issue>), <fpage>1401</fpage>&#x2013;<lpage>1409</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0902307</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivshina</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lasko</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Richter</surname> <given-names>J. D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cytoplasmic polyadenylation element binding proteins in development, health, and disease</article-title>. <source>Annu. Rev. Cell Dev. Biol.</source> <volume>30</volume>, <fpage>393</fpage>&#x2013;<lpage>415</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-cellbio-101011-155831</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanwal</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Kramer</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Gifford</surname> <given-names>A. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Development, validation, and evaluation of a simple machine learning model to predict cirrhosis mortality</article-title>. <source>JAMA network Open</source> <volume>3</volume> (<issue>11</issue>), <elocation-id>e2023780</elocation-id>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.23780</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karasinska</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Topham</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Kalloger</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Jang</surname> <given-names>G. H.</given-names>
</name>
<name>
<surname>Denroche</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Culibrk</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Altered gene expression along the glycolysis-Cholesterol synthesis axis is associated with outcome in pancreatic cancer</article-title>. <source>Clin. Cancer Res. an Off. J. Am. Assoc. Cancer Res.</source> <volume>26</volume> (<issue>1</issue>), <fpage>135</fpage>&#x2013;<lpage>146</lpage>. doi: <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-19-1543</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Chae</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Inhibition of endoplasmic reticulum stress alleviates lipopolysaccharide-induced lung inflammation through modulation of NF-&#x3ba;B/HIF-1&#x3b1; signaling pathway</article-title>. <source>Sci. Rep.</source> <volume>3</volume>, <fpage>1142</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep01142</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Fujikawa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kozawa</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Oxidative stress sensing by the iron-sulfur cluster in the transcription factor, SoxR</article-title>. <source>J. inorganic Biochem.</source> <volume>133</volume>, <fpage>87</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2013.11.008</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komorowski</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Green</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Tatham</surname> <given-names>K. C.</given-names>
</name>
<name>
<surname>Seymour</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Antcliffe</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Sepsis biomarkers and diagnostic tools with a focus on machine learning</article-title>. <source>EBioMedicine</source> <volume>86</volume>, <fpage>104394</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104394</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Identification of potential early diagnostic biomarkers of sepsis</article-title>. <source>J. Inflammation Res.</source> <volume>14</volume>, <fpage>621</fpage>&#x2013;<lpage>631</lpage>. doi: <pub-id pub-id-type="doi">10.2147/JIR.S298604</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Integrated analysis of multi-omics data reveals T cell exhaustion in sepsis</article-title>. <source>Front. Immunol.</source> <volume>14</volume>, <elocation-id>1110070</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2023.1110070</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Machine learning identifies pan-cancer landscape of nrf2 oxidative stress response pathway-related genes</article-title>. <source>Oxid. Med. Cell. Longevity</source> <volume>2022</volume>, <fpage>8450087</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2022/8450087</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Escobar</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Greene</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Soule</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Whippy</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Angus</surname> <given-names>D. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Hospital deaths in patients with sepsis from 2 independent cohorts</article-title>. <source>Jama</source> <volume>312</volume> (<issue>1</issue>), <fpage>90</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2014.5804</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Vunikili</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>K. W.</given-names>
</name>
<name>
<surname>Abdu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Belman</surname> <given-names>S. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses</article-title>. <source>Briefings Bioinf.</source> <volume>21</volume> (<issue>4</issue>), <fpage>1182</fpage>&#x2013;<lpage>1195</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bib/bbz059</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marinkovi&#x107;</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Koenis</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>de Camp</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Jablonowski</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Graber</surname> <given-names>N.</given-names>
</name>
<name>
<surname>de Waard</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>S100A9 links inflammation and repair in myocardial infarction</article-title>. <source>Circ. Res.</source> <volume>127</volume> (<issue>5</issue>), <fpage>664</fpage>&#x2013;<lpage>676</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.315865</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Badovinac</surname> <given-names>V. P.</given-names>
</name>
<name>
<surname>Griffith</surname> <given-names>T. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>CD4 T cell responses and the sepsis-induced immunoparalysis state</article-title>. <source>Front. Immunol.</source> <volume>11</volume>, <elocation-id>1364</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.01364</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maruzs</surname> <given-names>T.</given-names>
</name>
<name>
<surname>L&#x151;rincz</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Szatm&#xe1;ri</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Sz&#xe9;plaki</surname> <given-names>S.</given-names>
</name>
<name>
<surname>S&#xe1;ndor</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Lakatos</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Retromer ensures the degradation of autophagic cargo by maintaining lysosome function in drosophila</article-title>. <source>Traffic (Copenhagen Denmark)</source> <volume>16</volume> (<issue>10</issue>), <fpage>1088</fpage>&#x2013;<lpage>1107</lpage>. doi: <pub-id pub-id-type="doi">10.1111/tra.12309</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maslove</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>B. M.</given-names>
</name>
<name>
<surname>McLean</surname> <given-names>A. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Identification of sepsis subtypes in critically ill adults using gene expression profiling</article-title>. <source>Crit. Care (London England)</source> <volume>16</volume> (<issue>5</issue>), <fpage>R183</fpage>. doi: <pub-id pub-id-type="doi">10.1186/cc11667</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McBride</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Owen</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Stothers</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Luan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Burelbach</surname> <given-names>K. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The metabolic basis of immune dysfunction following sepsis and trauma</article-title>. <source>Front. Immunol.</source> <volume>11</volume>, <elocation-id>1043</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.01043</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ming</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Q.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Integrated analysis of gene co-expression network and prediction model indicates immune-related roles of the identified biomarkers in sepsis and sepsis-induced acute respiratory distress syndrome</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <elocation-id>897390</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.897390</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pauwels</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Provinciael</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Camps</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hartmann</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Vermeire</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Reduced DNAJC3 expression affects protein translocation across the ER membrane and attenuates the down-modulating effect of the translocation inhibitor cyclotriazadisulfonamide</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.3390/ijms23020584</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ping</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Metabolomics analysis of the development of sepsis and potential biomarkers of sepsis-induced acute kidney injury</article-title>. <source>Oxid. Med. Cell. Longevity</source> <volume>2021</volume>, <fpage>6628847</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2021/6628847</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Identification of molecular subtypes and a prognostic signature based on inflammation-Related genes in colon adenocarcinoma</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <elocation-id>769685</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.769685</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Read</surname> <given-names>A. D.</given-names>
</name>
<name>
<surname>Bentley</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Archer</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Dunham-Snary</surname> <given-names>K. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitochondrial iron-sulfur clusters: Structure, function, and an emerging role in vascular biology</article-title>. <source>Redox Biol.</source> <volume>47</volume>, <fpage>102164</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2021.102164</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Phipson</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Law</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res.</source> <volume>43</volume> (<issue>7</issue>), <elocation-id>e47</elocation-id>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudd</surname> <given-names>K. E.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Agesa</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Shackelford</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Tsoi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kievlan</surname> <given-names>D. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study</article-title>. <source>Lancet (London England)</source> <volume>395</volume> (<issue>10219</issue>), <fpage>200</fpage>&#x2013;<lpage>211</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Tuteja</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Reilly</surname> <given-names>M. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear Cells</article-title>. <source>PloS One</source> <volume>12</volume> (<issue>1</issue>), <elocation-id>e0169614</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0169614</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Markiel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ozier</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Baliga</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Ramage</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res.</source> <volume>13</volume> (<issue>11</issue>), <fpage>2498</fpage>&#x2013;<lpage>2504</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>She</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Identification and experimental validation of mitochondria-related genes biomarkers associated with immune infiltration for sepsis</article-title>. <source>Front. Immunol.</source> <volume>14</volume>, <elocation-id>1184126</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2023.1184126</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sibilio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Su&#xf1;er</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Alfara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mart&#xed;n</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Berenguer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Calon</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development</article-title>. <source>iScience</source> <volume>25</volume> (<issue>2</issue>), <fpage>103790</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.isci.2022.103790</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Deutschman</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Seymour</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Shankar-Hari</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Annane</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>The third international consensus definitions for sepsis and septic shock (Sepsis-3)</article-title>. <source>Jama</source> <volume>315</volume> (<issue>8</issue>), <fpage>801</fpage>&#x2013;<lpage>810</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>He</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>p53 deacetylation alleviates sepsis-induced acute kidney injury by promoting autophagy</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <elocation-id>685523</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.685523</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su&#xf1;er</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Sibilio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mart&#xed;n</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Castellazzi</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Reina</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Dotu</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Macrophage inflammation resolution requires CPEB4-directed offsetting of mRNA degradation</article-title>. <source>eLife</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.75873</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Men</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Research Progress of Biomarkers of Sepsis-Associated Encephalopathy</article-title>. <source>Intensive Care Res</source> <volume>3</volume>, <fpage>69</fpage>&#x2013;<lpage>76</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s44231-022-00023-2</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname> <given-names>L. K.</given-names>
</name>
<name>
<surname>Pickkers</surname> <given-names>P.</given-names>
</name>
<name>
<surname>van der Poll</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Sepsis-induced immunosuppression</article-title>. <source>Annu. Rev. Physiol.</source> <volume>84</volume>, <fpage>157</fpage>&#x2013;<lpage>181</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-physiol-061121-040214</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uhel</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Azzaoui</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Gr&#xe9;goire</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pangault</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Dulong</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Tadi&#xe9;</surname> <given-names>J. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>196</volume> (<issue>3</issue>), <fpage>315</fpage>&#x2013;<lpage>327</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201606-1143OC</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venet</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Davin</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Guignant</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Larue</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cazalis</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Darbon</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Early assessment of leukocyte alterations at diagnosis of septic shock</article-title>. <source>Shock (Augusta Ga)</source> <volume>34</volume> (<issue>4</issue>), <fpage>358</fpage>&#x2013;<lpage>363</lpage>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0b013e3181dc0977</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>S100A8/A9 in inflammation</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <elocation-id>1298</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.01298</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Beng</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kuai</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Protective effect of isosteviol sodium against LPS-induced multiple organ injury by regulating of glycerophospholipid metabolism and reducing macrophage-driven inflammation</article-title>. <source>Pharmacol. Res.</source> <volume>172</volume>, <fpage>105781</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2021.105781</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Integrated lipidomic and transcriptomic analysis reveals clarithromycin-induced alteration of glycerophospholipid metabolism in the cerebral cortex of mice</article-title>. <source>Cell Biol. Toxicol</source> <volume>39</volume>, <fpage>771</fpage>&#x2013;<lpage>793</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10565-021-09646-5</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname> <given-names>G. F.</given-names>
</name>
<name>
<surname>Maier</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Z&#xf6;nnchen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Breucha</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Seidlitz</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kutschick</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Analysis of circulating plasmacytoid dendritic cells during the course of sepsis</article-title>. <source>Surgery</source> <volume>158</volume> (<issue>1</issue>), <fpage>248</fpage>&#x2013;<lpage>254</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.surg.2015.03.013</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weng</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>National incidence and mortality of hospitalized sepsis in China</article-title>. <source>Crit. Care (London England)</source> <volume>27</volume> (<issue>1</issue>), <fpage>84</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13054-023-04385-x</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesselkamper</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Eppert</surname> <given-names>B. L.</given-names>
</name>
<name>
<surname>Motz</surname> <given-names>G. T.</given-names>
</name>
<name>
<surname>Lau</surname> <given-names>G. W.</given-names>
</name>
<name>
<surname>Hassett</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Borchers</surname> <given-names>M. T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection</article-title>. <source>J. Immunol. (Baltimore Md 1950)</source> <volume>181</volume> (<issue>8</issue>), <fpage>5481</fpage>&#x2013;<lpage>5489</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.181.8.5481</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation</article-title>. <source>Nat. Commun.</source> <volume>7</volume>, <fpage>13280</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms13280</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>R. Q.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>L. Y.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Z. F.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Y. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Advances in immune monitoring approaches for sepsis-induced immunosuppression</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <elocation-id>891024</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.891024</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma</article-title>. <source>Int. Immunopharmacol.</source> <volume>101</volume> (<issue>Pt A</issue>), <fpage>108293</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2021.108293</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Screening of key genes of sepsis and septic shock using bioinformatics analysis</article-title>. <source>J. Inflamm. Res.</source> <volume>14</volume>, <fpage>829</fpage>&#x2013;<lpage>841</lpage>. doi: <pub-id pub-id-type="doi">10.2147/JIR.S301663</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>C.</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets</article-title>. <source>Cytokine Growth factor Rev.</source> <volume>69</volume>, <fpage>90</fpage>&#x2013;<lpage>103</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cytogfr.2022.07.007</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>a). <article-title>S100A12 promotes inflammation and cell apoptosis in sepsis-induced ARDS via activation of NLRP3 inflammasome signaling</article-title>. <source>Mol. Immunol.</source> <volume>122</volume>, <fpage>38</fpage>&#x2013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molimm.2020.03.022</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kaufman</surname> <given-names>R. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>From endoplasmic-reticulum stress to the inflammatory response</article-title>. <source>Nature</source> <volume>454</volume> (<issue>7203</issue>), <fpage>455</fpage>&#x2013;<lpage>462</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature07203</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>b). <article-title>Deep learning-based clustering robustly identified two classes of sepsis with both prognostic and predictive values</article-title>. <source>EBioMedicine</source> <volume>62</volume>, <fpage>103081</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2020.103081</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Cata</surname> <given-names>J. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis</article-title>. <source>Clin. Trans. Med.</source> <volume>13</volume> (<issue>1</issue>), <elocation-id>e1170</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/ctm2.1170</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Ni</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis</article-title>. <source>J. Trans. Med.</source> <volume>19</volume> (<issue>1</issue>), <fpage>35</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12967-020-02698-x</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>
